跳至主要内容
临床试验/CTRI/2025/08/092432
CTRI/2025/08/092432招募中2/3 期

Add on effect of Panchajeeraka Guda in the management of Udavartini Yonivyapada with special reference to Primary Dysmenorrhea -A Randomized Controlled Clinical Trial

Dr Isha1 个研究点 分布在 1 个国家目标入组 46 人开始时间: 2025年9月1日最近更新:

试验速览

阶段
2/3 期
状态
招募中
发起方
入组人数
46
试验地点
1
主要终点
Significant reduction in pain intensity associated with Udavartini Yonivyapada in the

研究概览

简要总结

Primary Dysmenorrhea is a common illness in reproductive age. It is one of the most frequent cause of pelvic pain. It significantly affects the quality of life, such as limitation of daily activities and psychological stress, and is a major cause of school and work absenteeism.The prevalence of Primary Dysmenorrhea was estimated to be 70% with 34.7% complaining of severe Primary Dysmenorrhea. About 52.68% participants suffered from Primary Dysmenorrhea every month. Although modern science has approved drugs such as prostaglandin synthetase inhibitors, oral contraceptives, NSAIDs for the treatment, but they have limitations too. About 20% of women with Primary Dysmenorrhea are unresponsive to NSAIDs. Also these drugs have gastrointestinal side effects like nausea, constipation, vomiting, dry eyes, dry mouth and headache etc. Long term use may cause hepatotoxicity, nephrotoxicity and blurred vision etc. During menstruation, most experience gastrointestinal upsets as associated symptoms which in turn are increased by analgesics and anti-spasmodic drugs. Some drugs like selective COX-2 inhibitors have cardiovascular risks. Even the Combined oral contraceptives are unacceptable in young women and who want to conceive.This reveals a clinical gap and growing need for an approach that is effective, safe and sustainable.In Ayurvedic classics, it can be considered as Udavartini Yonivyapada and have various treatments like Matra Basti, Uttar Basti, Snehana, Swedana and oral medicines. Matra Basti has shown effectiveness in relieving symptoms, but for enhanced and sustained relief, there is a need to explore additional oral medications that can support Agni , regulate Vata and reduce *Shoola.*Considering this, Panchajeeraka Guda, mentioned in the context of Striroga Chikitsa in Chakradatta will be taken, considering its properties such as Vata Kaph hara, Vata anulomana, Deepana, Pachana, Shoolprashaman etc. Hence this study aims to evaluate the add on effect of Panchajeeraka Guda along with Tila Taila Matra Basti in the management of Udavartini Yonivyapada.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
15.00 Year(s) 至 25.00 Year(s)(—)
性别
Female

入选标准

  • Patients fulfilling the diagnostic criteria.
  • 15 to 25 years of age.
  • Painful menstruation for at least 3 consecutive cycles.
  • Regular menstrual cycles ranging from 21 to 35 days.
  • With average amount of menstrual flow.
  • Basti Yogya.
  • Willing to participate in the study.

排除标准

  • Diagnosed patients of secondary dysmenorrhea or with pelvic pathology (Eg-Endometriosis, fibroids, pelvic inflammatory disease etc.) 2) With irregular menstrual cycles.
  • Patients with systemic diseases like Diabetes, Hypertension, Thyroid dysfunction, Malignancy etc.
  • HIV, VDRL, HBsAG positive Patients.
  • Women using intrauterine contraceptive devices.
  • Lactating women.

结局指标

主要结局

Significant reduction in pain intensity associated with Udavartini Yonivyapada in the

时间窗: 0 th day, 2nd Month Menstrual cycle, 3rd Month Menstrual cycle

group receiving Panchajeeraka Guda and Tila Taila Matra Basti as compared to the

时间窗: 0 th day, 2nd Month Menstrual cycle, 3rd Month Menstrual cycle

Group receiving Tila Taila Matra Basti Alone.

时间窗: 0 th day, 2nd Month Menstrual cycle, 3rd Month Menstrual cycle

次要结局

  • 1. The Combined Therapy (Panchajeeraka Guda & Tila Taila Matra Basti) will Show a(greater reduction in associated Symptoms Compared to Tila Taila Matra Basti.)

研究者

发起方
Dr Isha
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Isha

KAHERS Shri B M Kankanawadi Ayurveda Mahavidyalaya Post Graduate Studies and Research Centre

研究点 (1)

Loading locations...

相似试验